Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease

Patent No. EP1793855 (titled "Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease") was filed by Elan Pharmaceuticals on Aug 9, 2005. The application was issued on Jan 19, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREAug 14, 2019MILLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1793855

ELAN PHARMACEUTICALS
Application Number
EP05783732A
Filing Date
Aug 9, 2005
Status
Patent Maintained As Amended
Dec 17, 2021
Publication Date
Jan 19, 2022